Recent Updates
Recently added Catalysts
TPST Positive Sentiment Score: 70/100

Tempest to Present at the 44th Annual TD Cowen Healthcare Conference

Monday, February 26, 2024 1 min read
Key Takeaway: Tempest Therapeutics, Inc. (Nasdaq: TPST) announced that its CEO, Stephen Brady, will present at the 44th Annual TD Cowen Healthcare Conference on March 4, 2024. The focus of the presentation will be on the company's efforts to develop first-in-class targeted and immune-mediated therapeutics for cancer. Tempest is a clinical-stage biotechnology company based in Brisbane, California, with a diverse portfolio aimed at treating various tumors through novel mechanisms. Interested parties can access the presentation through the investor section of Tempest's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tempest Therapeutics is presenting at a major healthcare conference.
  • The company is focused on developing innovative cancer therapies.
  • Stephen Brady's participation showcases leadership engagement.

Full Press Release Details

BRISBANE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that Stephen Brady, president and chief executive officer of Tempest, will present at the 44th Annual TD Cowen Healthcare Conference on Monday, March 4, 2024 at 9:10 a.m. ET.
To access the live or archived recording of the presentation, please visit the investor section of the Tempest website at https://ir.tempesttx.com.
About Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest is headquartered in Brisbane, California. More information about Tempest can be found on the company’s website at www.tempesttx.com.
Investor & Media Contacts
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

Frequently Asked Questions

When will Tempest Therapeutics present at the TD Cowen Conference?

Tempest Therapeutics will present on March 4, 2024, at 9:10 a.m. ET.

What type of therapeutics is Tempest developing?

Tempest is developing targeted and immune-mediated therapeutics for cancer.

Where is Tempest Therapeutics headquartered?

Tempest Therapeutics is headquartered in Brisbane, California.

How can I access the presentation recording?

You can access the presentation recording on the Tempest investor website.

What range of studies does Tempest's portfolio include?

Tempest's portfolio includes early research and later-stage randomized global studies.

Tags: TPST Viatris Investor Conferences Healthcare Tempest Therapeutics cancer therapy healthcare conference Brisbane
Last updated: Feb 26, 2024